• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Annual Changes to the Nasdaq-100 Index®

    12/13/24 8:00:00 PM ET
    $AXON
    $ILMN
    $MRNA
    $MSTR
    Ordnance And Accessories
    Industrials
    Medical Specialities
    Health Care
    Get the next $AXON alert in real time by email

    NEW YORK, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced the results of the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX), which will become effective prior to market open on Monday, December 23, 2024.

    The following three companies will be added to the Index: Palantir Technologies Inc. (NASDAQ:PLTR), MicroStrategy Incorporated (NASDAQ:MSTR), and Axon Enterprise, Inc. (NASDAQ:AXON).

    The Nasdaq-100 Index® is composed of 100 of the largest non-financial companies1 listed on The Nasdaq Stock Market® and dates to January 1985 – nearly 40 years ago –when it was launched along with the Nasdaq Financial-100™ Index, which is comprised of 100 of the largest financial stocks on Nasdaq® These indexes act as benchmarks for financial products such as options, futures, and funds. The Nasdaq-100® is reconstituted each year in December, timed to coincide with the quadruple witch expiration Friday of the quarter.

    The Nasdaq-100 Index® is the basis of the Invesco QQQ Trust (NASDAQ:QQQ) which aims to provide investment results that, before expenses, correspond with the Nasdaq-100 Index® performance. In addition, options, futures and structured products based on the Nasdaq-100 Index® and the Invesco QQQ Trust trade on various exchanges.

    As a result of the reconstitution, the following three companies will be removed from the Index: Illumina, Inc. (NASDAQ:ILMN), Super Micro Computer, Inc. (NASDAQ:SMCI), and Moderna, Inc. (NASDAQ:MRNA).

    Information

    For information about the three companies to be added to the Nasdaq-100 Index®, please visit the following respective company websites:

    Palantir Technologies Inc. – https://www.palantir.com/

    MicroStrategy Incorporated – https://www.microstrategy.com/

    Axon Enterprise, Inc. – https://www.axon.com/

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    _______________

    1 As outlined in the Nasdaq-100 Index® Methodology

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X, or at www.nasdaq.com. 

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The Nasdaq OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG - 

    Media Relations Contact Investor Relations Contact 
    Name: Jennifer Lawson

    Email: [email protected]

     Name: Index Client Services

    Email: [email protected]

     
        


    Primary Logo

    Get the next $AXON alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AXON
    $ILMN
    $MRNA
    $MSTR

    CompanyDatePrice TargetRatingAnalyst
    Nasdaq Inc.
    $NDAQ
    11/20/2025$110.00Equal-Weight → Overweight
    Morgan Stanley
    Strategy Inc
    $MSTR
    11/10/2025Sell → Neutral
    Monness Crespi & Hardt
    Super Micro Computer Inc.
    $SMCI
    11/6/2025Hold → Buy
    Argus
    Strategy Inc
    $MSTR
    10/15/2025$473.00Buy
    China Renaissance
    Axon Enterprise Inc.
    $AXON
    9/24/2025$893.00Overweight
    Piper Sandler
    Super Micro Computer Inc.
    $SMCI
    9/16/2025$46.00Mkt Perform
    Bernstein
    Illumina Inc.
    $ILMN
    8/12/2025$94.00Outperform → Neutral
    Daiwa Securities
    Axon Enterprise Inc.
    $AXON
    8/5/2025$900.00Hold → Buy
    Craig Hallum
    More analyst ratings

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Gottlieb Scott bought $61,065 worth of shares (500 units at $122.13), increasing direct ownership by 4% to 12,523 units (SEC Form 4)

    4 - ILLUMINA, INC. (0001110803) (Issuer)

    11/5/25 4:05:20 PM ET
    $ILMN
    Medical Specialities
    Health Care

    Director Partovi Hadi bought $1,004,920 worth of shares (1,358 units at $740.00), increasing direct ownership by 0.57% to 237,938 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    8/15/25 4:36:59 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    Director Briger Peter L Jr bought $19,800,000 worth of Series A Perpetual Stretch Preferred Stock (220,000 units at $90.00) (SEC Form 4)

    4 - MICROSTRATEGY Inc (0001050446) (Issuer)

    7/29/25 6:20:52 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    SEC Filings

    View All

    SEC Form 485BXT filed by Invesco QQQ Trust, Series 1

    485BXT - INVESCO QQQ TRUST, SERIES 1 (0001067839) (Filer)

    11/21/25 4:05:06 PM ET
    $QQQ

    SEC Form 144 filed by Palantir Technologies Inc.

    144 - Palantir Technologies Inc. (0001321655) (Subject)

    11/20/25 6:22:52 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    SEC Form 144 filed by Palantir Technologies Inc.

    144 - Palantir Technologies Inc. (0001321655) (Subject)

    11/20/25 6:07:57 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    NASDAQ upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded NASDAQ from Equal-Weight to Overweight and set a new price target of $110.00

    11/20/25 7:58:08 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Strategy Inc upgraded by Monness Crespi & Hardt

    Monness Crespi & Hardt upgraded Strategy Inc from Sell to Neutral

    11/10/25 8:37:33 AM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    Super Micro Computer upgraded by Argus

    Argus upgraded Super Micro Computer from Hold to Buy

    11/6/25 7:30:56 AM ET
    $SMCI
    Computer Manufacturing
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT Isner Joshua was granted 67,910 shares, increasing direct ownership by 28% to 306,289 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    11/17/25 5:19:29 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    CPO & CTO Kunins Jeffrey C was granted 20,618 shares, increasing direct ownership by 28% to 94,563 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    11/17/25 5:15:25 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    CHIEF EXECUTIVE OFFICER Smith Patrick W was granted 97,015 shares, increasing direct ownership by 3% to 3,120,997 units (SEC Form 4)

    4 - AXON ENTERPRISE, INC. (0001069183) (Issuer)

    11/17/25 5:13:01 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Supermicro Announces Participation in Upcoming Investor Events

    Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced its participation in the upcoming investor conferences: UBS Global Technology and AI Conference Date: December 1-2, 2025 1x1 meetings only Location: Scottsdale, AZ Raymond James TMT & Consumer Conference Date: December 8, 2025 Fireside Chat: 1:40pm ET Location: New York, NY Barclays Global Technology Conference Date: December 11, 2025 Fireside Chat: 9:50am PT Location: San Francisco, CA About Super Micro Computer, Inc. Supermicro (NASDAQ:SMCI) is a global leader in Application-Optimized Total IT Solutions. Founded and operating

    11/20/25 9:05:00 AM ET
    $SMCI
    Computer Manufacturing
    Technology

    Palantir Achieves Information Security Registered Assessors Program (IRAP) PROTECTED Level, Unlocking New Opportunities in Australia

    Palantir Technologies Inc. (NASDAQ:PLTR), a leading builder of secure, artificial intelligence (AI) software, today announced it has achieved the IRAP PROTECTED level under the Australian Information Security Registered Assessors Program (IRAP), further enabling Australian government agencies and commercial organizations to leverage Palantir Foundry with confidence. IRAP assessment completion at the PROTECTED level is a key requirement for organizations working with Australian government agencies. Palantir's achievement enables a broader set of Australian customers to leverage Palantir's platforms—while meeting stringent national security and privacy standards. The assessment was conducte

    11/20/25 6:59:00 AM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $AXON
    $ILMN
    $MRNA
    $MSTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Leadership Updates

    Live Leadership Updates

    View All

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Surf Air Mobility Appoints Shawn Pelsinger to Board of Directors

    Mr. Pelsinger was formerly the Global Head of Corporate Development & Senior Counsel of Palantir Technologies. Surf Air Mobility Inc. (NYSE:SRFM) ("the Company", "Surf Air Mobility"), a leading regional air mobility platform, announced today the appointment of Shawn Pelsinger to the Company's Board of Directors, effective October 8, 2025. Mr. Pelsinger is currently Chief Legal Officer and Chief Administrative Officer of Acrisure, a global fintech provider of solutions across insurance, reinsurance, payroll, benefits, cybersecurity, and real estate services. Prior to joining Acrisure, Mr. Pelsinger was the Global Head of Corporate Development & Senior Counsel of Palantir Technologies (

    10/8/25 6:30:00 AM ET
    $PLTR
    $SRFM
    Computer Software: Prepackaged Software
    Technology
    Transportation Services
    Consumer Discretionary

    Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

    Brian McKernan joins as CEO to further advance Predicta's clinical impact, including its non-invasive diagnostic for Multiple Myeloma Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised an oversubscribed $23.4 million Series A led by Engine Ventures. Additional participating investors include Illumina Ventures, Lightchain Capital, Mass General Brigham Ventures, ACS BrightEdge, Binney Street Capital of Dana-Farber Cancer Institute and Myeloma Solutions Fund. The capital will be used to expand Predicta's team and CLIA-approved lab infrastructure, and advance commercialization of the company's first

    10/1/25 9:00:00 AM ET
    $ILMN
    Medical Specialities
    Health Care

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Financials

    Live finance-specific insights

    View All

    Palantir and FTAI Aviation Enter Strategic Partnership to Accelerate the Transformation of Aircraft Engine Maintenance, Repair and Exchange

    Palantir (NASDAQ:PLTR), a leading provider of AI software, and FTAI Aviation Ltd. (NASDAQ:FTAI), a global leader in aircraft engine maintenance, today announced a multi-year strategic partnership, which will allow FTAI to leverage Palantir's Artificial Intelligence Platform ("AIP") across FTAI's global maintenance footprint. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117324507/en/ Through this partnership, Palantir's AIP is helping FTAI transform productivity and reduce manufacturing costs by improving maintenance scheduling and inventory optimization across FTAI's operations worldwide. This includes transforming its inte

    11/17/25 6:59:00 AM ET
    $FTAI
    $PLTR
    Misc Corporate Leasing Services
    Industrials
    Computer Software: Prepackaged Software
    Technology

    Supermicro Announces First Quarter Fiscal Year 2026 Financial Results

    Super Micro Computer, Inc. (NASDAQ:SMCI) ("Supermicro" or the "Company"), a Total IT Solution Provider for AI, Cloud, Storage, and 5G/Edge, today announced unaudited financial results for its first quarter of fiscal year 2026 ended September 30, 2025. First Quarter Fiscal Year 2026 Highlights Net sales of $5.0 billion versus $5.8 billion in Q4'25 and $5.9 billion in Q1'25 Gross margin of 9.3% versus 9.5% in Q4'25 and 13.1% in Q1'25 Net income of $168 million versus $195 million in Q4'25 and $424 million in Q1'25 Diluted net income per common share of $0.26 versus $0.31 in Q4'25 and $0.67 in Q1'25 Non-GAAP diluted net income per common share of $0.35 versus $0.73 in Q1'25 C

    11/4/25 4:05:00 PM ET
    $SMCI
    Computer Manufacturing
    Technology

    Axon reports Q3 2025 revenue of $711 million, up 31% year over year

    SCOTTSDALE, Ariz., Nov. 4, 2025 /PRNewswire/ -- Software & Services revenue grows 41% to $305 millionAnnual recurring revenue grows 41% to $1.3 billionNet loss was $2 million, with non-GAAP net income of $98 million and Adjusted EBITDA of $177 millionRaises full year revenue outlook to approximately $2.74 billion, 31% annual growth, up from $2.65 billion to $2.73 billion previously.Fellow shareholders, Axon delivered another record quarter, with revenue growing 31% year over year to $711 million — our seventh consecutive quarter of growth above 30% — and GAAP net loss margin o

    11/4/25 4:01:00 PM ET
    $AXON
    Ordnance And Accessories
    Industrials

    $AXON
    $ILMN
    $MRNA
    $MSTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Illumina Inc.

    SC 13G/A - ILLUMINA, INC. (0001110803) (Subject)

    12/6/24 10:11:24 AM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Illumina Inc.

    SC 13G - ILLUMINA, INC. (0001110803) (Subject)

    12/5/24 7:27:01 PM ET
    $ILMN
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by MicroStrategy Incorporated

    SC 13G - MICROSTRATEGY Inc (0001050446) (Subject)

    11/14/24 6:24:12 PM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology